| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.73 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |